| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.5 | 0.07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |